Eprinomectin 5% Injection

Verify with FDA CVM →

228 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
228
Total Reports
28
Deaths Reported
1230.0%
Death Rate

Active Ingredients

Eprinomectin 5% Injection

Administration Routes

UnknownSubcutaneousParenteralIntramuscularOtherTopicalOphthalmicCutaneousOral

Species Affected

Cattle 148
Human 39
Unknown 35
Goat 4
Dog 1
Alpaca 1

Most Affected Breeds

Unknown 76
Aberdeen Angus 48
Cattle (unknown) 24
Cattle (other) 22
Crossbred Bovine/Cattle 17
Brangus 8
Holstein-Friesian also known as Holstein 5
Hereford cattle 4
Jersey 4
Goat (unknown) 3

Most Reported Reactions

Lack of efficacy - NOS 38
Digestive tract disorder NOS 30
Lack of efficacy (endoparasite) - NOS 30
Death 26
Injection site lesion 24
Low weight gain 24
Injection site swelling 19
INEFFECTIVE, PARASITE(S) NOS 14
Uncoded sign 14
Unthrifty 12
Poor coat condition 11
Skin lesion NOS 10

Outcome Breakdown

Outcome Unknown
140 (70.4%)
Died
27 (13.6%)
Recovered/Normal
23 (11.6%)
Ongoing
7 (3.5%)
Euthanized
1 (0.5%)
Recovered with Sequela
1 (0.5%)

Data Summary

Metric Value
Total adverse event reports 228
Reports involving death 28
Case-fatality rate (reported events) 1230.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Eprinomectin 5% Injection Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 228 adverse event reports referencing Eprinomectin 5% Injection, including 28 reports in which the animal died — a 1230.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Eprinomectin 5% Injection. Reported administration routes include Unknown, Subcutaneous, Parenteral, Intramuscular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Eprinomectin 5% Injection reports are Cattle (148 reports), Human (39 reports), Unknown (35 reports), with Cattle accounting for the largest share. Within those species, Unknown (76), Aberdeen Angus (48), Cattle (unknown) (24) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Eprinomectin 5% Injection are Lack of efficacy - NOS (38), Digestive tract disorder NOS (30), Lack of efficacy (endoparasite) - NOS (30), Death (26). Of the 199 reports with a coded outcome, Outcome Unknown is the leading category at 70.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Eprinomectin 5% Injection.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial